🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Alemtuzumab is an antibody that reduces the strength of the immune system t...
Status
Recruiting
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-11
Trial ID
NCT05501756
Treatments Being Tested
The development and progression of multiple sclerosis seem to be driven by ...
Status
Unknown
Location
Functional Imaging Unit, Department of Clinical Physiology, Nuclear medicine and PET, Glostrup Hospital
Start Date
2017-01-01
Trial ID
NCT03193086
Treatments Being Tested
This study is being done to test a transplant method that may have fewer si...
Status
Suspended
Location
St. Jude Children's Research Hospital
Start Date
2020-04-30
Trial ID
NCT04362293
Transplant rejection occurs when a patient's body does not recognize the ne...
Status
Completed
Location
University of Wisconsin - Department of Medicine
Start Date
2003-11
Trial ID
NCT00078559
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
Background: Sickle cell disease (SCD) is an inherited disorder of the bloo...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2022-05-12
Trial ID
NCT05357482
Treatments Being Tested
The goal of this clinical research study is to find out how well Campath (a...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2008-08
Trial ID
NCT00771602
Treatments Being Tested
A multicentre controlled phase II trial to compare the efficacy and safety ...
Status
Terminated
Location
Universitätsklinikum Hamburg-Eppendorf
Start Date
2021-08-27
Trial ID
NCT04971005
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer gro...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2005-01
Trial ID
NCT00301834
This study is designed to test the ability to achieve donor hematopoietic e...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-07-11
Trial ID
NCT01626092